To deliver on this front, the industry must go beyond simple process optimization and incremental changes and instead embrace a bold vision of the future.
The question is: How will Life Sciences organizations design and implement an enterprise-wide, scalable, sustainable transformation agenda that enables them to get the future they want?
In this scenario, it’s best to talk to someone who’s been highly active in this field for over 30 years and has over 15,000 specialists.
Life Sciences is a priority at Capgemini, and it’s our fastest-growing Industry. Our current footprint includes over 100 global biopharma companies — for which we are delivering end-to-end digital transformation and technology services from strategy to implementation at scale — in over 40 countries.
Enabling breakthrough innovations at speed and at scale
Life Sciences organizations are facing mounting pressure to accelerate timelines, reduce costs, and improve probability of success across the entire lifecycle. As an end-to-end transformation partner, Capgemini helps clients leverage data, AI, automation, and digital technology to industrialize the drug discovery.
Accelerating time to market
Few Life Sciences organizations have captured the full potential of automation and AI across the enterprise. A true leader in Industry 4.0, Capgemini helps clients strategize, deploy and scale Next Generation Smart Operations across manufacturing, supply chain operations, and regulatory affairs, helping clients unlock valuable efficiencies and drive meaningful, lasting change.
Embracing digitization for a people-centric future
Connected Health programs have matured, but stagnated, as organizations struggle to develop compelling integrated portfolio strategies. Capgemini is the Life Sciences industry’s premier enterprise growth partner for Connected Health, helping organizations drive the development and launch of successful, scalable digital products.
